--- title: "PLUR.US (PLUR.US) — 相关新闻" type: "Symbol" locale: "zh-CN" url: "https://longbridge.com/zh-CN/quote/PLUR.US/news.md" symbol: "PLUR.US" name: "PLUR.US" parent: "https://longbridge.com/zh-CN/quote/PLUR.US.md" datetime: "2026-03-13T10:54:32.383Z" locales: - [en](https://longbridge.com/en/quote/PLUR.US/news.md) - [zh-CN](https://longbridge.com/zh-CN/quote/PLUR.US/news.md) - [zh-HK](https://longbridge.com/zh-HK/quote/PLUR.US/news.md) --- > 支持的语言: [English](https://longbridge.com/en/quote/PLUR.US/news.md) | [繁體中文](https://longbridge.com/zh-HK/quote/PLUR.US/news.md) # PLUR.US (PLUR.US) — 相关新闻 ### [AI startup Callosum completes $10.25 million financing, led by Plural](https://longbridge.com/zh-CN/news/276986107.md) *2026-02-26T05:21:16.000Z* > AI startup Callosum has completed a $10.25 million financing round, led by Plural. The company is developing software ai ### [Pluri | 10-Q: FY2026 Q2 Revenue: USD 198 K](https://longbridge.com/zh-CN/news/275806798.md) *2026-02-12T21:06:33.000Z* ### [Plurilock Security meldet vier Vertragsverlängerungen über 1,19 Millionen Dollar](https://longbridge.com/zh-CN/news/274808223.md) *2026-02-04T12:03:46.000Z* ### [Plurilock Security Secures $1.19 Million in Cybersecurity Contract Renewals](https://longbridge.com/zh-CN/news/274808199.md) *2026-02-04T12:03:46.000Z* ### [Pluri Inc. Faces Nasdaq Delisting Risk Over Market Value Compliance](https://longbridge.com/zh-CN/news/273422057.md) *2026-01-22T21:06:27.000Z* ### [Pluri Completes First Phase of Placenta-Derived Biomaterials Program With Resbiomed](https://longbridge.com/zh-CN/news/273386059.md) *2026-01-22T14:15:14.000Z* ### [Pluri Inc. Expands Manufacturing Collaboration With Remedy Cell](https://longbridge.com/zh-CN/news/270488776.md) *2025-12-22T12:03:15.000Z* ### [The German team uses a "stirring tank" to mass-produce artificial lungs - lung-like organs! Future organ transplants may say goodbye to donor shortages](https://longbridge.com/zh-CN/news/269493261.md) *2025-12-12T08:45:27.000Z* > The team from the University of Duisburg-Essen in Germany has developed a method for the automated production of lung-li